Comparative Cancer Transcriptomics

Comparative Cancer Transcriptomics is a systematic research framework that integrates transcriptomic profiling across species, tissues, or cancer types to identify conserved and divergent gene expression patterns underlying tumorigenesis, thereby distinguishing itself from general transcriptomic analyses by its explicit comparative, cross-contextual design aimed at uncovering evolutionarily and mechanistically significant regulatory alterations in cancer.

75

Publications

4.1K

Citations

778

Authors

271

Institutions

Publications per year

2017–2026

34

Authors

778

  1. MS
    Manfred Schartl

    University of Würzburg, Germany

    2 publications · 51 citations

    2

    h-index

  2. KC
    Kenichi Chiba

    Kyoto University, Japan

    2 publications · 139 citations

    2

    h-index

  3. YS
    Yuichi Shiraishi

    The University of Tokyo, Japan

    2 publications · 139 citations

    2

    h-index

  4. MU
    Mathias Uhlén

    KTH Royal Institute of Technology, Sweden

    2 publications · 171 citations

    2

    h-index

  5. RL
    Robert L. Eoff

    University of Arkansas for Medical Sciences, United States

    1 publications · 29 citations

    1

    h-index

1–5 of 778

Venues

  1. PLoS ONE

    9 publications · 389 citations

    9

    h-index

  2. BMC Genomics

    4 publications · 281 citations

    4

    h-index

  3. Cancers

    4 publications · 107 citations

    4

    h-index

  4. Cancer Research

    3 publications · 230 citations

    3

    h-index

  5. BMC Cancer

    3 publications · 63 citations

    3

    h-index

1–5